Popular Sleep Supplement Linked to Increased Risk of Heart Failure, Study Suggests
New research examining a widely used over‑the‑counter sleep aid has raised concerns among health experts about its potential long‑term impact on cardiovascular health. The study, which analyzed medical records of adults diagnosed with chronic insomnia, identified a statistically significant association between regular use of the supplement and a higher incidence of heart failure. Although the findings have not yet undergone peer review, they add to a growing body of literature questioning the safety of prolonged consumption of certain sleep‑related products.
The retrospective analysis covered a cohort of roughly 12,000 individuals aged 30 to 75 who reported daily use of the supplement for at least six months. Researchers compared the health outcomes of this group with a matched control group that did not use the supplement. Results indicated that the supplement‑using group experienced heart failure diagnoses at a rate approximately 1.8 times greater than the control group, after adjusting for common risk factors such as hypertension, diabetes, and smoking.
Medical professionals cautioned that the observational nature of the study does not prove causation, but they emphasized the need for further investigation. "These initial data suggest a possible link that warrants deeper clinical evaluation," a spokesperson for a national cardiology association said. Public health officials also noted that while the supplement is generally regarded as safe for short‑term use, consumers should be aware of potential risks associated with chronic intake, especially if they have underlying heart conditions.
Industry analysts highlighted that the supplement market has grown rapidly in recent years, driven by increasing rates of sleep disorders and a shift toward self‑medication. In response to the study, several manufacturers issued statements affirming the product’s compliance with existing safety regulations and pledged to cooperate with ongoing research efforts. Regulatory agencies indicated they are monitoring the situation but have not announced any immediate policy changes.
Experts recommend that individuals using the supplement for extended periods consult their healthcare providers to assess personal risk factors and explore alternative treatments for insomnia. Ongoing clinical trials are expected to provide more definitive evidence regarding the supplement’s cardiovascular effects, which could influence future guidelines and consumer usage patterns.
